Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.88 USD | +0.85% | +0.44% | -18.69% |
05-23 | Transcript : Arrowhead Pharmaceuticals, Inc. - Special Call | |
05-20 | Arrowhead Pharmaceuticals Lung Disease Treatment Study Shows Lower Serum sRAGE in Asthma Patients | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.69% | 3.09B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Transcript : Arrowhead Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 09, 2024